Drug Trial Radar · NCT06153693
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension
Last checked: Nov 19, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,083
Actual
Start
Nov 22, 2023
Primary completion
Dec 10, 2024
Study completion Jan 24, 2025
Sponsor
- Lead sponsor
- Mineralys Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 1, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3 trial to evaluate the BP-lowering effect of lorundrostat (an aldosterone synthase inhibitor) in subjects with uncontrolled and resistant hypertension taking between 2 and 5 anti-hypertensive (AHT) medications.
Conditions
- Hypertension
Interventions
PlaceboDrug
Placebo once daily (QD) for 12 weeks
lorundrostat Dose 1Drug
50 mg lorundrostat Dose 1 once daily (QD) for 12 weeks
lorundrostat Dose 2Drug
50 mg lorundrostat Dose 1 once daily (QD) for 6 weeks then 100 mg lorundrostat Dose 2 once daily (QD) for 6 weeks for subjects who meet prespecified criteria
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in automated office BP (AOBP) SBP at Week 6 in subjects randomized to lorundrostat 50 mg QD compared to subjects randomized to placeboTime frame: Week 6
Locations
184 sites in 13 countries. Site status is shown where the registry gives one.
Advanced Cardiovascular, LLC - Alexander City Office
Alexander City, Alabama
Central Research Associates, Inc
Birmingham, Alabama
Cardiology, P.C.
Birmingham, Alabama
Synexus (Radiant Research, Inc) - Alabama - Simon Williamson Clinic Location
Birmingham, Alabama
G & L Research LLC - Foley
Foley, Alabama
Accel Research Sites (ARS) - Birmingham Clinical Research Unit
Vestavia Hills, Alabama
Del Sol Research
Tucson, Arizona
Entertainment Medical Group, Inc.
Beverly Hills, California
Amicis Research Center - Granada Hills
Granada Hills, California
Amicis Research Center - Northridge
Granada Hills, California
Marvel Clinical Research, LLC
Huntington Beach, California
Amicis Research Center
Northridge, California
Pasadena Clinical Trials
Pasadena, California
Empire Clinical Research (ECR)
Pomona, California
Clinical Trials Research (CTR) - Sacramento
Sacramento, California
North America Research Institute
San Dimas, California
Amicis Research Center - Valencia
Valencia, California
CMR of Greater New Haven
Hamden, Connecticut
Chase Medical Research, LLC - Hamden
Waterbury, Connecticut
Indago Research and Health Center
Hialeah, Florida
Clinical Neuroscience Solutions (CNS Healthcare) - Jacksonville
Jacksonville, Florida
Nuovida Research Center Corp
Miami, Florida
Clinical Neuroscience Solutions (CNS Healthcare) - Orlando Research Center
Orlando, Florida
AES Orlando
Orlando, Florida
Patron Medical - Andres Patron D.O. (Patron Ventures, LLC)
Pembroke Pines, Florida
Pines Care Research Center, LLC
Pembroke Pines, Florida
Progressive Medical Research
Port Orange, Florida
Clinical Research of West Florida (CRWF) - Clearwater
Tampa, Florida
AES The Villages
The Villages, Florida
Morehouse School of Medicine (MSM)
Atlanta, Georgia
ClinCept, LLC
Columbus, Georgia
Accel Research Sites- Decatur
Decatur, Georgia
Georgia Clinical Research Center, Inc
Lawrenceville, Georgia
Elite Clinical Trials
Blackfoot, Idaho
Rocky Mountain Diabetes Center
Idaho Falls, Idaho
Solaris Clinical Research (SCR)
Meridian, Idaho
Synexus (Radiant Research, Inc) - Chicago
Chicago, Illinois
Healthcare Research Network-Chicago, Illinois (Flossmoor) Location
Flossmoor, Illinois
Koch Family Medicine, S.C.
Morton, Illinois
Southern Illinois University School of Medicine - SIU Clinics - SIU Internal Medicine
Springfield, Illinois
Showing 40 of 184 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.